These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6547094

  • 1. Investigation of the venoconstrictor effect of 8' hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in man.
    Aellig WH.
    Eur J Clin Pharmacol; 1984; 26(2):239-42. PubMed ID: 6547094
    [Abstract] [Full Text] [Related]

  • 2. [Effect of ergot alkaloids on venous tonus determined in superficial hand veins in situ].
    Aellig WH.
    Cardiology; 1976; 61 suppl 1():302-8. PubMed ID: 975144
    [Abstract] [Full Text] [Related]

  • 3. Venoconstrictor effects of dihydroergotamine after intranasal and intramuscular administration.
    Aellig WH, Rosenthaler J.
    Eur J Clin Pharmacol; 1986; 30(5):581-4. PubMed ID: 3758146
    [Abstract] [Full Text] [Related]

  • 4. Venoconstrictor effect of dihydroergotamine in superficial hand veins.
    Aellig WH.
    Eur J Clin Pharmacol; 1974; 7(2):137-9. PubMed ID: 4855381
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dihydroergotamine: pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs.
    Müller-Schweinitzer E, Rosenthaler J.
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):686-93. PubMed ID: 2442535
    [Abstract] [Full Text] [Related]

  • 11. In vitro studies on the duration of action of dihydroergotamine.
    Müller-Schweinitzer E.
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(2):88-91. PubMed ID: 7372380
    [Abstract] [Full Text] [Related]

  • 12. Influence of ergot compounds on compliance of superficial hand veins in man.
    Aellig WH.
    Postgrad Med J; 1976 Jun; 52suppl 1():21-23. PubMed ID: 959123
    [No Abstract] [Full Text] [Related]

  • 13. Ex vivo studies after oral treatment of the beagle with dihydroergotamine.
    Müller-Schweinitzer E, Rosenthaler J.
    Eur J Pharmacol; 1983 Apr 22; 89(1-2):1-8. PubMed ID: 6861880
    [Abstract] [Full Text] [Related]

  • 14. Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins.
    Thulesius O, Gjöres JE, Berlin E.
    Eur J Clin Pharmacol; 1979 Apr 22; 16(6):423-4. PubMed ID: 93544
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Interactions of dihydroergotamine with etilefrine in human leg veins in vitro and in situ.
    Barthel W, Glusa E, Koth W.
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb 22; 25(2):63-9. PubMed ID: 2881898
    [Abstract] [Full Text] [Related]

  • 19. Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins.
    Müller-Schweinitzer E.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct 22; 327(4):299-303. PubMed ID: 6096723
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.